Gee JM - Search Results

1

EGFR and cancer prognosis.

Nicholson RI, Gee JM, Harper ME. Nicholson RI, et al. Among authors: gee jm. Eur J Cancer. 2001 Sep;37 Suppl 4:S9-15. doi: 10.1016/s0959-8049(01)00231-3. Eur J Cancer. 2001. PMID: 11597399 Review.

2

Differential expression of oestrogen regulated genes in breast cancer.

Manning DL, McClelland RA, Knowlden JM, Bryant S, Gee JM, Green CD, Robertson JF, Blamey RW, Sutherland RL, Ormandy CJ, et al. Manning DL, et al. Among authors: gee jm. Acta Oncol. 1995;34(5):641-6. doi: 10.3109/02841869509094041. Acta Oncol. 1995. PMID: 7546832

3

Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer.

Nicholson RI, Gee JM, Manning DL, Wakeling AE, Montano MM, Katzenellenbogen BS. Nicholson RI, et al. Among authors: gee jm. Ann N Y Acad Sci. 1995 Jun 12;761:148-63. doi: 10.1111/j.1749-6632.1995.tb31376.x. Ann N Y Acad Sci. 1995. PMID: 7625718 Review. No abstract available.

4

Immunocytochemical localization of Fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy.

Gee JM, Ellis IO, Robertson JF, Willsher P, McClelland RA, Hewitt KN, Blamey RW, Nicholson RI. Gee JM, et al. Int J Cancer. 1995 Aug 22;64(4):269-73. doi: 10.1002/ijc.2910640410. Int J Cancer. 1995. PMID: 7657391

5

Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA.

Hepburn PJ, Glynne-Jones E, Goddard L, Gee JM, Harper ME. Hepburn PJ, et al. Among authors: gee jm. Histochem J. 1995 Mar;27(3):196-203. Histochem J. 1995. PMID: 7797424

6

Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.

Nicholson RI, McClelland RA, Gee JM, Manning DL, Cannon P, Robertson JF, Ellis IO, Blamey RW. Nicholson RI, et al. Among authors: gee jm. Breast Cancer Res Treat. 1994 Jan;29(1):117-25. doi: 10.1007/BF00666187. Breast Cancer Res Treat. 1994. PMID: 7912565 Clinical Trial.

7

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy.

Gee JM, Robertson JF, Ellis IO, Willsher P, McClelland RA, Hoyle HB, Kyme SR, Finlay P, Blamey RW, Nicholson RI. Gee JM, et al. Int J Cancer. 1994 Dec 1;59(5):619-28. doi: 10.1002/ijc.2910590508. Int J Cancer. 1994. PMID: 7960234

8

Oestrogen-regulated genes in breast cancer: association of pLIV1 with lymph node involvement.

Manning DL, Robertson JF, Ellis IO, Elston CW, McClelland RA, Gee JM, Jones RJ, Green CD, Cannon P, Blamey RW, et al. Manning DL, et al. Among authors: gee jm. Eur J Cancer. 1994;30A(5):675-8. doi: 10.1016/0959-8049(94)90543-6. Eur J Cancer. 1994. PMID: 8080686

9

Transforming growth factor-alpha and endocrine sensitivity in breast cancer.

Nicholson RI, McClelland RA, Gee JM, Manning DL, Cannon P, Robertson JF, Ellis IO, Blamey RW. Nicholson RI, et al. Among authors: gee jm. Cancer Res. 1994 Apr 1;54(7):1684-9. Cancer Res. 1994. PMID: 8137282

10

The role of four oestrogen-responsive genes, pLIV1, pS2, pSYD3 and pSYD8, in predicting responsiveness to endocrine therapy in primary breast cancer.

Manning DL, McClelland RA, Gee JM, Chan CM, Green CD, Blamey RW, Nicholson RI. Manning DL, et al. Among authors: gee jm. Eur J Cancer. 1993;29A(10):1462-8. doi: 10.1016/0959-8049(93)90021-7. Eur J Cancer. 1993. PMID: 8398276

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results